HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

beta-hydroxyisovalerylshikonin

structure in first source
Also Known As:
beta-HIVS
Networked: 12 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Nakaya, Kazuyasu: 8 articles (02/2009 - 08/2002)
2. Nakajo, Shigeo: 7 articles (02/2009 - 08/2002)
3. Kajimoto, Sachiko: 5 articles (02/2009 - 02/2003)
4. Masuda, Yutaka: 4 articles (01/2008 - 08/2002)
5. Xu, Ying: 3 articles (01/2004 - 08/2002)
6. Itabe, Hiroyuki: 2 articles (02/2009 - 01/2008)
7. Shibuya, Masabumi: 2 articles (02/2009 - 08/2002)
8. Horie, Masayo: 2 articles (01/2008 - 10/2004)
9. Shibayama-Imazu, Toshiko: 2 articles (01/2008 - 10/2004)
10. Aiuchi, Toshihiro: 2 articles (10/2004 - 08/2002)

Related Diseases

1. Lung Neoplasms (Lung Cancer)
2. Neoplasms (Cancer)
3. Ovarian Neoplasms (Ovarian Cancer)
4. Leukemia
5. Squamous Cell Carcinoma (Epidermoid Carcinoma)

Related Drugs and Biologics

1. beta-hydroxyisovalerylshikonin
2. shikonin
3. Protein-Tyrosine Kinases (Tyrosine Kinase)
4. Cisplatin (Platino)
5. Adenosine Triphosphate (ATP)
6. Caspase 9
7. Caspase 8 (Caspase-8)
8. Caspase 3 (Caspase-3)
9. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
10. Etoposide (VP 16)

Related Therapies and Procedures

1. Therapeutics
2. Aftercare (After-Treatment)